Detalles de la búsqueda
1.
PRISM II: an open-label study to assess effectiveness of dextromethorphan/quinidine for pseudobulbar affect in patients with dementia, stroke or traumatic brain injury.
BMC Neurol
; 16: 89, 2016 Jun 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-27276999
2.
An open-label study to assess safety, tolerability, and effectiveness of dextromethorphan/quinidine for pseudobulbar affect in dementia: PRISM II results.
CNS Spectr
; 21(6): 450-459, 2016 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-26471212
3.
Eyelash growth in subjects treated with bimatoprost: a multicenter, randomized, double-masked, vehicle-controlled, parallel-group study.
J Am Acad Dermatol
; 66(5): 801-6, 2012 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-21899919
4.
Erratum to: PRISM II: an open-label study to assess effectiveness of dextromethorphan/quinidine for pseudobulbar affect in patients with dementia, stroke or traumatic brain injury.
BMC Neurol
; 16(1): 160, 2016 Sep 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-27590297
5.
Safety, Tolerability, and Effectiveness of Dextromethorphan/Quinidine for Pseudobulbar Affect Among Study Participants With Traumatic Brain Injury: Results From the PRISM-II Open Label Study.
PM R
; 10(10): 993-1003, 2018 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-29477412
6.
Dextromethorphan/Quinidine for Pseudobulbar Affect Following Stroke: Safety and Effectiveness in the PRISM II Trial.
PM R
; 2018 Jun 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-29964212
Resultados
1 -
6
de 6
1
Próxima >
>>